Therapeutic potential for cytokine antagonists: Thalidomide and pentoxifylline in Hansen's disease.

about

Therapeutic potential for cytokine antagonists: Thalidomide and pentoxifylline in Hansen's disease.

Item

http://www.wikidata.org/entity/Q35892890

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

1995年论文

@zh

1995年论文

@zh-cn

name

Therapeutic potential for cyto ...... xifylline in Hansen's disease.

@ast

Therapeutic potential for cyto ...... xifylline in Hansen's disease.

@en

type

Item

label

Therapeutic potential for cyto ...... xifylline in Hansen's disease.

@ast

Therapeutic potential for cyto ...... xifylline in Hansen's disease.

@en

prefLabel

Therapeutic potential for cyto ...... xifylline in Hansen's disease.

@ast

Therapeutic potential for cyto ...... xifylline in Hansen's disease.

@en

P1476

Therapeutic potential for cyto ...... xifylline in Hansen's disease.

@en

P2093

T C Peterson

http://www.w3.org/2001/XMLSchema#string

P2860

Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states

Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline.

ARDS, neutrophils, and pentoxifylline.

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.

Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.

Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity.

Reactional states in Hansen's disease: practical aspects of emergency management.

Leprosy and cell-mediated immunity.

P304

30-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/1995/503276

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1995-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22514378

http://www.w3.org/2001/XMLSchema#string

P921

thalidomide

P932

3327898

http://www.w3.org/2001/XMLSchema#string